Don't Ignore This Chart!

Pointing To A BioTech Breakout In XBI?

Greg Schnell

Greg Schnell

Chief Technical Analyst, Osprey Strategic

XBI, IBB, SBIO and numerous other Biotech ETF's have surged the first few days of the new year. They all look set to breakout so you might want to tune your eyes into the area for at least a few interesting charts. I thought the last two times were also going to break free, but the new year, new start might be just enough to get it done this time.

The SCTR is already above 90, so there is plenty of momentum as it tests the big trend here. It wouldn't take much to make new one-year highs in Relative Strength (purple) to really push it onto the institutional investors desk. The volume has been about 15% above average so it is very interesting here.


Tom Bowley and I will be covering off the 2017 Market Outlook in a special edition Saturday morning webinar. Click Here to register on our Webinars page. We'll see you there!

Good trading,
Greg Schnell, CMT, MFTA

 
Greg Schnell
About the author: , CMT, MFTA is Chief Technical Analyst at Osprey Strategic specializing in intermarket and commodities analysis. He is also the co-author of Stock Charts For Dummies (Wiley, 2018). Based in Calgary, Greg is a board member of the Canadian Society of Technical Analysts (CSTA) and the chairman of the CSTA Calgary chapter. He is an active member of both the CMT Association and the International Federation of Technical Analysts (IFTA). Learn More